Bio-Rad Laboratories (BIO) Competitors $251.56 +0.91 (+0.36%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Do institutionals and insiders believe in MTD or BIO? 95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable valuation & earnings, MTD or BIO? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.87B6.49$863.14M$40.1030.15Bio-Rad Laboratories$2.57B2.67-$1.84B-$76.20-3.30 Does the media refer more to MTD or BIO? In the previous week, Mettler-Toledo International had 10 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 14 mentions for Mettler-Toledo International and 4 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.70 beat Bio-Rad Laboratories' score of 1.61 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 14 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bio-Rad Laboratories 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility and risk, MTD or BIO? Mettler-Toledo International has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Is MTD or BIO more profitable? Mettler-Toledo International has a net margin of 22.17% compared to Bio-Rad Laboratories' net margin of -85.16%. Bio-Rad Laboratories' return on equity of 4.32% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International22.17% -556.22% 26.27% Bio-Rad Laboratories -85.16%4.32%3.03% Do analysts rate MTD or BIO? Mettler-Toledo International currently has a consensus price target of $1,300.36, indicating a potential upside of 7.55%. Bio-Rad Laboratories has a consensus price target of $324.25, indicating a potential upside of 28.90%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42Bio-Rad Laboratories 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryMettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$6.85B$10.43B$5.56B$20.71BDividend YieldN/A2.07%5.22%3.71%P/E Ratio-3.3017.0327.6628.10Price / Sales2.6729.34421.6138.38Price / Cash24.2122.9936.8922.53Price / Book1.073.668.034.58Net Income-$1.84B$235.40M$3.18B$985.54M7 Day Performance3.10%2.15%2.93%2.79%1 Month Performance14.13%1.07%1.72%4.37%1 Year Performance-9.16%-10.17%34.39%15.08% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.8672 of 5 stars$251.56+0.4%$324.25+28.9%-9.2%$6.85B$2.57B-3.307,700Positive NewsAnalyst UpgradeMTDMettler-Toledo International4.2851 of 5 stars$1,175.56-0.8%$1,300.36+10.6%-10.2%$24.43B$3.87B29.3218,000News CoveragePositive NewsWATWaters4.5569 of 5 stars$349.93-0.7%$388.00+10.9%+22.4%$20.82B$2.96B31.758,200Trending NewsAnalyst UpgradeILMNIllumina4.8787 of 5 stars$95.41+0.7%$127.39+33.5%-7.4%$15.10B$4.37B-15.729,030Positive NewsTECHBio-Techne4.977 of 5 stars$51.45-0.8%$72.00+39.9%-25.6%$8.07B$1.16B62.743,100Positive NewsCRLCharles River Laboratories International4.0466 of 5 stars$151.64+1.1%$171.85+13.3%-21.3%$7.45B$4.05B-233.2920,100Analyst DowngradeBRKRBruker4.7681 of 5 stars$41.20-1.4%$52.89+28.4%-31.2%$6.24B$3.45B79.2311,396PACBPacific Biosciences of California2.3178 of 5 stars$1.24-3.9%$2.06+66.2%+20.6%$372.10M$154.01M-0.44730News CoverageGap DownHBIOHarvard Bioscience4.1163 of 5 stars$0.44-4.3%$3.00+576.0%-83.6%$19.62M$94.14M-0.34490Trending NewsTMOThermo Fisher Scientific4.9931 of 5 stars$405.83-0.6%$604.05+48.8%-20.7%$153.20B$42.88B23.80125,000Positive NewsAAgilent Technologies4.7377 of 5 stars$118.06-0.9%$140.92+19.4%-4.1%$33.54B$6.51B29.1518,100News CoveragePositive NewsEx-DividendInsider Trade Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
